Gilbert Lynn Marks

Insider Reports History

Location
Cape May, NJ
Signature
/s/ Lucy Day, Attorney-in-Fact for Gilbert Lynn Marks
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gilbert Lynn Marks:

Company Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Director Common Stock 75,309 $87,358 $1.16 12 Jan 2026 Direct
AN2 Therapeutics, Inc. Director Stock Option (Right to Buy) 20,400 20 Feb 2026 Direct

Insider Reports Filed by Gilbert Lynn Marks

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANTX AN2 Therapeutics, Inc. 20 Feb 2026 1 $0 4 Director 23 Feb 2026, 16:29
ANTX AN2 Therapeutics, Inc. 12 Jan 2026 1 $0 4 Director 14 Jan 2026, 17:06
ANTX AN2 Therapeutics, Inc. 10 Oct 2025 1 $0 4 Director 14 Oct 2025, 16:01
ANTX AN2 Therapeutics, Inc. 10 Jul 2025 1 $0 4 Director 11 Jul 2025, 18:20
ANTX AN2 Therapeutics, Inc. 22 May 2025 1 $0 4 Director 23 May 2025, 16:51
ANTX AN2 Therapeutics, Inc. 10 Apr 2025 1 $0 4 Director 11 Apr 2025, 16:55
ANTX AN2 Therapeutics, Inc. 19 Dec 2024 1 $0 4 Director 23 Dec 2024, 18:38
ANTX AN2 Therapeutics, Inc. 19 Jun 2024 1 $0 4 Director 21 Jun 2024, 18:20
ANTX AN2 Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 20:44
ANTX AN2 Therapeutics, Inc. 12 May 2022 1 $0 4 Director 16 May 2022, 21:11
ANTX AN2 Therapeutics, Inc. 24 Mar 2022 0 $0 3 Director 24 Mar 2022, 21:22